Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
An update from Little Green Pharma Ltd. ( (AU:LGP) ) is now available.
Little Green Pharma Ltd has announced the appointment of Paul Long as a director, effective March 1, 2025. This appointment is accompanied by a detailed disclosure of Mr. Long’s interests in the company’s securities, including both direct and indirect holdings. The announcement highlights Mr. Long’s significant stake in the company, which may influence its strategic direction and governance. This move is likely to impact the company’s operations and could have implications for its stakeholders, reflecting a potential shift in leadership dynamics.
More about Little Green Pharma Ltd.
Little Green Pharma Ltd is a company operating in the pharmaceutical industry, focusing on the production and distribution of medical cannabis products. The company is dedicated to providing high-quality cannabis-based medicines to improve patient outcomes and has a strong presence in the emerging medical cannabis market.
YTD Price Performance: 12.50%
Average Trading Volume: 144,595
Technical Sentiment Consensus Rating: Sell
Current Market Cap: A$40.89M
Learn more about LGP stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue